T1	Participants 71 108	nocturnal asthma: a multicentre trial
T2	Participants 110 141	French Multicentre Study Group.
T3	Participants 368 631	Ninety six patients with nocturnal asthma, (forced expiratory volume in one second (FEV1) 60-90% of predicted value, reversibility > or = 15%, at least two nocturnal awakenings per week) were eligible for a multicentre, double-blind, double-dummy cross-over study
